Clinical Research
Helius Therapeutics to Supply New Phase 2 Cannabis Sleep Trial
Helius Therapeutics has today announced a supply agreement with the University of Auckland for a new Phase 2 trial into cannabis as a sleep aid for patients which chronic back pain.